Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
abandon, accommodate, accomodate, announced, attorney, broadly, CDK, cell, chemotherapy, disease, dismissing, environment, goal, kinase, lengthy, lerociclib, lung, met, moot, NSCLC, parallel, prevalent, science, strong, voluntarily
Removed:
approach, gain, good, highest, opportunity, target
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view